Cargando…

Compression therapy for leg oedema in patients with heart failure

The presence of chronic heart failure (CHF) results in a significant risk of leg oedema. Medical compression (MC) treatment is one of the basic methods of leg oedema elimination in patients with chronic venous disease and lymphedema, but it is not routinely considered in subjects with CHF‐related sw...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbanek, Tomasz, Juśko, Maciej, Kuczmik, Wacław B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524111/
https://www.ncbi.nlm.nih.gov/pubmed/32710511
http://dx.doi.org/10.1002/ehf2.12848
_version_ 1783588492201164800
author Urbanek, Tomasz
Juśko, Maciej
Kuczmik, Wacław B.
author_facet Urbanek, Tomasz
Juśko, Maciej
Kuczmik, Wacław B.
author_sort Urbanek, Tomasz
collection PubMed
description The presence of chronic heart failure (CHF) results in a significant risk of leg oedema. Medical compression (MC) treatment is one of the basic methods of leg oedema elimination in patients with chronic venous disease and lymphedema, but it is not routinely considered in subjects with CHF‐related swelling. In the study, an overview of the current knowledge related to the benefits and risk of using MC in the supportive treatment of leg oedema in CHF patients is presented. The available studies dedicated the comprehensive management of leg swelling using MC in CHF patients published in the English language literature till December 2019 were evaluated in term of the treatment efficacy and safety. In studies performed on CHF populations, manual lymphatic drainage, MC stocking, multilayer bandaged, as well as intermittent pneumatic compression or electric calf stimulations were used. The current evidence is based on non‐randomized studies, small study cohorts, as well as very heterogenous populations. The use of the intermittent pneumatic compression in CHF patients significantly increases the right auricular pressure and mean pulmonary artery pressures as well as decreases systemic vascular resistance in most patients without the clinical worsening. The transient and rapid increase in the human atrial natriuretic peptide, after an application of the MC stocking in New York Heart Association (NYHA) class II patients was observed without clinical exacerbation. An application of the multilayer bandages in NYHA classes III and IV patients lead a significant increase in the right arterial pressure and lead to transient deterioration of the right and the left ventricular functions. In the manual lymphatic drainage study, aside from expected leg circumference reduction, no clinical worsening was observed. In a pilot study performed in a small cohort of CHF patients, electrical calf stimulation use resulted in a reduction in the lean mass of the legs without cardiac function worsening. The use of local leg compression can be considered stable CHF patients without decompensated heart function for both CHF‐related oedema treatment and for treatment of the concomitant diseases leading to leg swelling occurrence. The use of MC in more severe classes of CHF (NYHA III and IV) should be the subject of future clinical studies to select the safest and most efficient compression method as well as to select the patients who benefit most from this kind of treatment.
format Online
Article
Text
id pubmed-7524111
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75241112020-10-02 Compression therapy for leg oedema in patients with heart failure Urbanek, Tomasz Juśko, Maciej Kuczmik, Wacław B. ESC Heart Fail Reviews The presence of chronic heart failure (CHF) results in a significant risk of leg oedema. Medical compression (MC) treatment is one of the basic methods of leg oedema elimination in patients with chronic venous disease and lymphedema, but it is not routinely considered in subjects with CHF‐related swelling. In the study, an overview of the current knowledge related to the benefits and risk of using MC in the supportive treatment of leg oedema in CHF patients is presented. The available studies dedicated the comprehensive management of leg swelling using MC in CHF patients published in the English language literature till December 2019 were evaluated in term of the treatment efficacy and safety. In studies performed on CHF populations, manual lymphatic drainage, MC stocking, multilayer bandaged, as well as intermittent pneumatic compression or electric calf stimulations were used. The current evidence is based on non‐randomized studies, small study cohorts, as well as very heterogenous populations. The use of the intermittent pneumatic compression in CHF patients significantly increases the right auricular pressure and mean pulmonary artery pressures as well as decreases systemic vascular resistance in most patients without the clinical worsening. The transient and rapid increase in the human atrial natriuretic peptide, after an application of the MC stocking in New York Heart Association (NYHA) class II patients was observed without clinical exacerbation. An application of the multilayer bandages in NYHA classes III and IV patients lead a significant increase in the right arterial pressure and lead to transient deterioration of the right and the left ventricular functions. In the manual lymphatic drainage study, aside from expected leg circumference reduction, no clinical worsening was observed. In a pilot study performed in a small cohort of CHF patients, electrical calf stimulation use resulted in a reduction in the lean mass of the legs without cardiac function worsening. The use of local leg compression can be considered stable CHF patients without decompensated heart function for both CHF‐related oedema treatment and for treatment of the concomitant diseases leading to leg swelling occurrence. The use of MC in more severe classes of CHF (NYHA III and IV) should be the subject of future clinical studies to select the safest and most efficient compression method as well as to select the patients who benefit most from this kind of treatment. John Wiley and Sons Inc. 2020-07-25 /pmc/articles/PMC7524111/ /pubmed/32710511 http://dx.doi.org/10.1002/ehf2.12848 Text en © 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Reviews
Urbanek, Tomasz
Juśko, Maciej
Kuczmik, Wacław B.
Compression therapy for leg oedema in patients with heart failure
title Compression therapy for leg oedema in patients with heart failure
title_full Compression therapy for leg oedema in patients with heart failure
title_fullStr Compression therapy for leg oedema in patients with heart failure
title_full_unstemmed Compression therapy for leg oedema in patients with heart failure
title_short Compression therapy for leg oedema in patients with heart failure
title_sort compression therapy for leg oedema in patients with heart failure
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524111/
https://www.ncbi.nlm.nih.gov/pubmed/32710511
http://dx.doi.org/10.1002/ehf2.12848
work_keys_str_mv AT urbanektomasz compressiontherapyforlegoedemainpatientswithheartfailure
AT juskomaciej compressiontherapyforlegoedemainpatientswithheartfailure
AT kuczmikwacławb compressiontherapyforlegoedemainpatientswithheartfailure